Molmed SpA (EUR)
MLM
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.47 | 0.48
52-Wk Range |
Last Close0.47
Mkt Cap (m)218.98
Dividend yield-
ISINIT0001080248
Volume7,100,799
Exchange VenueMIL

Company Profile

Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validation of therapies to treat cancer.

Key Information
Price/Earning-
Price/Book10.10
Price/Sales6.47
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Annual Report
en 31/12/2018

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)1114192328-
Operating Income (m)-13-21-14-8-4-
Net Income (m)-13-21-14-8-4-
Basic EPS-0.05-0.06-0.03-0.02-0.01-
Avg. Diluted Shares Outstanding (m)285376422437463-
Balance Sheet
EUR201420152016201720182019
Current Assets (m)1941312726-
Non Current Assets (m)1016161615-
Total Assets (m)3057474341-
Current Liabilities (m)1219181413-
Total Liabilities (m)------
Total Equity (m)1232222524-
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-6-16-12-10-3-
Capital Expenditure (m)-5-6-2-2-2-
Figures are quoted in EUR unless stated otherwise
-
No change
0.47
Last Price